$7.62
-0.17 (-2.12%)
QLT, Inc. (USA) (NASDAQ:QLTI)
CAPS Rating:
A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.
A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.